Home > 약제과 소식 > 최신 의학 정보최신 의학 정보
최신약물정보 (FDA 승인 약물 2012.12-2013.2 )
게시일 2014-02-03 12:24
Abthrax (raxibacumab) GlaxoSmithKline; For the treatment and prevention of anthrax, Approved December of 2012
Eliquis (apixaban) Bristol-Myers Squibb; For the prevention of stroke and systemic embolism resulting from nonvalvular atrial fibrillation, Approved December 2012
Kynamro (mipomersen sodium) Genzyme; For the treatment of homozygous familial hypercholesterolemia, Approved January 2013
Nesina (alogliptin) Takeda; For the treatment of type II diabetes mellitus, Approved January 2013
Eliquis (apixaban) Bristol-Myers Squibb; For the prevention of stroke and systemic embolism resulting from nonvalvular atrial fibrillation, Approved December 2012
Kynamro (mipomersen sodium) Genzyme; For the treatment of homozygous familial hypercholesterolemia, Approved January 2013
Nesina (alogliptin) Takeda; For the treatment of type II diabetes mellitus, Approved January 2013
코멘트 0|조회 982
인쇄| 최희영
-
최신약물정보 (FDA 승인 약물 2013.3-2013.5) 2014-02-03 12:31 - 발프로산(Valproate) 안전성 서한 2013-5-8 식약청 2014-02-03 12:30
- 최신약물정보 (FDA 승인 약물 2012.12-2013.2 )
- 노바스크 복약지도 변경 (January 2013, Pfizer USA Insert 7.3 .. 2014-02-03 12:23
- 살카토닌 함유 제제 허가사항 변경 지시 2014-02-03 12:23